PAM
PTGX icon

Panagora Asset Management’s Protagonist Therapeutics PTGX Stock Holding History

Panagora Asset Management’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.3M Sell
116,609
-8,775
-7% -$777K 0.05% 299
2025
Q4 		$11M Sell
125,384
-23,345
-16% -$1.91M 0.04% 284
2025
Q3 		$9.88M Sell
148,729
-61
-0% -$3.47K 0.04% 279
2025
Q2 		$8.22M Sell
148,790
-1,118
-0.7% -$53.7K 0.04% 282
2025
Q1 		$7.25M Buy
+149,908
New +$6.28M 0.04% 294
2022
Q1 		– Sell
-7,225
Closed -$247K – 1577
2021
Q4 		$247K Sell
7,225
-24,212
-77% -$765K ﹤0.01% 1425
2021
Q3 		$557K Sell
31,437
-105,761
-77% -$4.51M ﹤0.01% 1271
2021
Q2 		$6.16M Sell
137,198
-92,315
-40% -$3.05M 0.03% 394
2021
Q1 		$5.94M Sell
229,513
-7,169
-3% -$181K 0.03% 423
2020
Q4 		$4.77M Buy
236,682
+77,828
+49% +$1.68M 0.03% 443
2020
Q3 		$3.11M Buy
158,854
+8,160
+5% +$153K 0.02% 506
2020
Q2 		$2.66M Buy
150,694
+105,195
+231% +$1.32M 0.02% 572
2020
Q1 		$321K Buy
+45,499
New +$341K ﹤0.01% 1296
2018
Q4 		– Sell
-3,107
Closed -$32K – 2508
2018
Q3 		$32K Sell
3,107
-2,666
-46% -$22.9K ﹤0.01% 2127
2018
Q2 		$39K Hold
5,773
– – ﹤0.01% 2087
2018
Q1 		$50K Buy
+5,773
New +$109K ﹤0.01% 2033

Other funds holding PTGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Panagora Asset Management's PTGX Position: Q1 2026 in Review

Panagora Asset Management reduced its Protagonist Therapeutics (PTGX) stake by 7% in Q1 2026, selling an estimated $777K and leaving 116,609 shares worth $12.3M. The position accounts for 0.05% of the portfolio, ranked #299.

Panagora Asset Management first reported a position in PTGX in Q1 2018 and has held it in 16 quarters since. 317 funds tracked by Wall St. Rank hold PTGX as of Q1 2026.

  • Panagora Asset Management held 116,609 shares of Protagonist Therapeutics worth $12.3M as of Q1 2026.
  • Panagora Asset Management sold 8,775 Protagonist Therapeutics shares in Q1 2026, an estimated $777K.
  • Protagonist Therapeutics made up 0.05% of Panagora Asset Management's portfolio in Q1 2026, its #299 holding.
  • Panagora Asset Management first reported a position in Protagonist Therapeutics in Q1 2018 and has held it in 16 quarters since.
  • 317 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.